BBIO vs CMS
BridgeBio Pharma Inc (BBIO) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
CMS does not have a complete income-statement cache yet.
BBIO currently screens at market cap $13.24B. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the BBIO and CMS stock pages for the full models.
Not investment advice.